Transforming Cancer Care with Radiopharmaceutical Innovation
We are developing
next-generation targeted therapies for
treatment-resistant cancer.
We are developing
next-generation targeted therapies for
treatment-resistant cancer.
Transforming
Cancer Care with Radiopharmaceutical Innovation
We are developing
next-generation targeted therapies for
treatment-resistant cancer.
Our Mission
Our Mission
Our Mission
Nuclide Therapeutics is pioneering
radiopharmaceutical therapies that unite nuclear medicine with biotechnology.
Our mission is to provide hope and new treatment options for patients with
cancers that have limited alternatives.
Nuclide Therapeutics is pioneering
radiopharmaceutical therapies that unite nuclear medicine with biotechnology.
Our mission is to provide hope and new treatment options for patients with cancers that have limited alternatives.
Nuclide Therapeutics is pioneering
radiopharmaceutical therapies that unite nuclear medicine with biotechnology.
Our mission is to provide hope and new treatment options for patients with
cancers that have limited alternatives.
Technology
Our technology will bring hope to therapy-resistant patients
For cancers with no effective treatments the need is urgent.
Technology
Our technology will bring hope to therapy-resistant patients
For cancers with no effective treatments the need is urgent.
Technology
Our technology will bring hope to therapy-resistant patients
For cancers with no effective treatments the need is urgent.
Our Pipeline
Our Pipeline
Our lead diagnostic and therapeutic programs are progressing through preclinical evaluation and first-in-human studies.
About
Bringing together experts in radiopharmaceutical development
Led by a multidisciplinary founding team combining decades of experience across chemistry, molecular biology, and radiopharmaceutical innovation:
About
Bringing together experts in radiopharmaceutical development
Led by a multidisciplinary founding team combining decades of experience across chemistry, molecular biology, and radiopharmaceutical innovation:
About
Bringing together experts in radiopharmaceutical development
Led by a multidisciplinary founding team combining decades of experience across chemistry, molecular biology, and radiopharmaceutical innovation:
News
News
News
Stay up to date with the latest from NuclideTx
From research breakthroughs and company milestones to opportunities to develop your career as we shape the future of radionuclide therapy.
Connect with us
Email us and keep updated on our clinical trial and pipeline development on LinkedIn.
Connect with us
Email us and keep updated on our clinical trial and pipeline development on LinkedIn.
© 2025 Nuclide Therapeutics, All rights reserved
Privacy Policy
Cookie Policy
© 2025 Nuclide Therapeutics, All rights reserved
Privacy Policy
Cookie Policy
© 2025 Nuclide Therapeutics, All rights reserved
Privacy Policy
Cookie Policy